asperger and rett syndrome 10 marker each
| # | Marker | Detail |
|---|---|---|
| 1 | Normal to superior intelligence | IQ is preserved; children often excel academically. About 1% of autistic children have normal or superior intelligence - this group typifies Asperger syndrome. |
| 2 | No clinically significant language delay | Language develops on time (unlike classic autism), but use of language is pedantic, one-sided, and lacks pragmatics (semantic-pragmatic disorder). |
| 3 | Profound social disability | Severely impaired social reciprocity - poor eye contact, difficulty reading social cues, inability to interpret actions/emotions of others; treats people like objects. |
| 4 | Restricted, repetitive interests | Intense, narrow preoccupations (e.g., train schedules, astronomy) pursued with encyclopedic knowledge. Insistence on environmental sameness. |
| 5 | Motor clumsiness | Inept in athletic activities; poor coordination; clumsy gait - unlike classic autism where motor milestones may be precocious. |
| 6 | Special cognitive abilities ("idiot savant") | Unusually adept at reading, calculating, drawing, or memorizing. Temple Grandin famously described thinking in pictures rather than semantic language. |
| 7 | Male predominance (8:1 ratio) | Male-to-female ratio of 8:1, higher than the overall autism spectrum (4:1 overall; ~1:1 for severe autism) - per Emery's Medical Genetics. |
| 8 | Literal, concrete thinking | Striking ability to understand isolated facts but not concepts or conceptual groupings; difficulty generalizing from an idea. |
| 9 | Onset recognition later in childhood | Social deficits become apparent at school age when peer interaction demands increase; early development may appear relatively unremarkable. |
| 10 | Absent psychogenesis; polygenic tendency | No psychosocial cause; familial aggregation of autistic traits with polygenic inheritance; ~71% concordance in monozygotic twins for ASD spectrum. |
Sources: Adams & Victor's Principles of Neurology 12e; Emery's Medical Genetics; Kaplan & Sadock's Comprehensive Textbook of Psychiatry
| # | Marker | Detail |
|---|---|---|
| 1 | Apparently normal early development | Normal prenatal, perinatal, and postnatal development until 6-18 months of age. This normal window is a key diagnostic feature. |
| 2 | Developmental regression | After the normal period, rapid loss of previously acquired skills - speech, purposeful hand use, and social interaction. Children are often initially misdiagnosed with autism. |
| 3 | Stereotypic hand-wringing movements | Characteristic and highly recognizable midline hand-wringing, hand-washing, or hand-squeezing movements - the hallmark that first caught Rett's attention in 1966. |
| 4 | Loss of purposeful hand use | Purposeful hand function is lost and replaced by the stereotypic movements; child can no longer pick up objects or self-feed meaningfully. |
| 5 | Decelerating head growth (acquired microcephaly) | Head circumference normal at birth but growth decelerates during the regression phase, leading to microcephaly. |
| 6 | Gait abnormalities and ataxia | Progressive motor deterioration with ataxic, wide-based, or toe-walking gait; most patients become wheelchair-bound by their teens. |
| 7 | Breathing irregularities (awake) | Episodes of hyperventilation, breath-holding, and irregular breathing patterns while awake - a distinctive autonomic feature. |
| 8 | Seizures | Epilepsy occurs in the majority; seizures develop during the regression phase and can be refractory. EEG abnormalities are universal. |
| 9 | Scoliosis and spasticity | Progressive spasticity, rigidity, and scoliosis/kyphosis develop after apparent stabilization; contribute to morbidity in later stages. |
| 10 | MECP2 gene mutation (Xq28) | ~95% of classic Rett syndrome cases have a pathogenic MECP2 variant. The protein is a methyl-CpG binding chromatin regulator; loss causes failure of transcriptional silencing. Almost exclusively in females - males with MECP2 mutations are typically embryonic lethal. |
Bonus feature: Prolonged QTc on ECG - may explain the increased incidence of unexplained sudden death. Patients can survive into the 6th-7th decade.
Sources: Thompson & Thompson Genetics in Medicine 9e; Tietz Textbook of Laboratory Medicine 7e; Adams & Victor's Principles of Neurology 12e; Harrison's Principles of Internal Medicine 22e
| Feature | Asperger Syndrome | Rett Syndrome |
|---|---|---|
| Sex | Male >> Female (8:1) | Almost exclusively female |
| Genetics | Polygenic/multifactorial (SHANK3, 16p) | MECP2 mutation (X-linked dominant) |
| Language | Preserved but pragmatically abnormal | Lost during regression |
| Intelligence | Normal to superior | Profound intellectual disability |
| Motor | Clumsy but functional | Progressive - wheelchair by teens |
| DSM-5 status | Subsumed into ASD | Separate diagnosis (excluded from ASD criteria) |
| Regression | Subtle/gradual | Rapid and dramatic (6-18 months) |
treatment for both...etiology, and prognosis ..and examples of famous people who have such disorders
famous people with Asperger syndrome Rett syndrome confirmed diagnosed
famous people diagnosed Asperger syndrome list Elon Musk Greta Thunberg Anthony Hopkins
| Approach | Details |
|---|---|
| Behavioral therapy (ABA) | Applied Behavior Analysis is the cornerstone; improves social skills, communication, and adaptive behaviors |
| Special education | Structured, individualized programs; children with Asperger's often thrive in academic settings |
| SSRIs (fluoxetine, citalopram) | Reduce repetitive behaviors and mood swings; widely prescribed |
| Risperidone (atypical antipsychotic) | FDA-approved for severe irritability, self-injurious behavior, aggression, and tantrums |
| Speech/language therapy | Targets pragmatic language deficits (tone, turn-taking, topic maintenance) |
| Social skills training | Group-based programs that teach reading social cues, facial expressions, and peer interaction |
| Occupational therapy | Addresses motor clumsiness and sensory integration issues |
| Psychiatric/family counseling | Guides families in forming realistic expectations; addresses comorbid anxiety and depression |
| Secretin | Early anecdotal reports were not reproducible in controlled studies - no longer recommended |
| Person | Field | Notes |
|---|---|---|
| Elon Musk | Tech entrepreneur | Self-disclosed on SNL in 2021; said Asperger's contributes to his singular focus |
| Greta Thunberg | Climate activist | Publicly identifies with Asperger's; calls it her "superpower" |
| Anthony Hopkins | Actor | Diagnosed in his 70s; credits his ability to fully immerse in roles to being on the spectrum |
| Daryl Hannah | Actress | Diagnosed with autism early in her career; found social demands of Hollywood particularly difficult |
| Dan Aykroyd | Actor/comedian | Has spoken openly about Asperger's; his obsession with ghosts and law enforcement inspired Ghostbusters |
| Susan Boyle | Singer | Diagnosed with Asperger's at age 51 after years of being misdiagnosed |
| Albert Einstein (retrospective) | Physicist | Widely speculated based on biographical accounts; delayed speech, intense narrow interests, social difficulties - no formal diagnosis |
| Alan Turing (retrospective) | Computer scientist | Similar retrospective assessment; obsessive focus, social awkwardness, literal communication style |
| Temple Grandin | Animal scientist/author | Explicitly described by Oliver Sacks; thinks in pictures rather than semantic language; tireless autism advocate |
| Intervention | Target |
|---|---|
| Anticonvulsants | Seizure control (majority of patients develop epilepsy) |
| SSRIs (e.g., sertraline) | Agitation, mood dysregulation |
| Carbidopa/Levodopa | Rigidity and movement difficulties |
| Melatonin | Sleep disturbances |
| Physical therapy | Maintain ambulation as long as possible; delay wheelchair dependency |
| Occupational therapy | Hand function, activities of daily living |
| Nutritional support | Weight loss and feeding difficulties are common |
| Scoliosis management | Bracing or surgical correction in severe cases |
| Cardiac monitoring | Prolonged QTc surveillance to reduce sudden death risk |
| Gene therapy (preclinical) | Active area of research; mouse models show rescue of phenotype when MECP2 is restored - clinical trials underway (clinicaltrials.gov) |
| Trofinetide (Daybue) | FDA-approved in 2023 - the first approved drug specifically for Rett syndrome; an IGF-1 analogue that reduces core symptoms |
| Feature | Asperger Syndrome | Rett Syndrome |
|---|---|---|
| Etiology | Polygenic, multifactorial; SHANK3, 16p deletions | Single gene: MECP2 mutation (Xq28) |
| Who is affected | Predominantly males (8:1) | Almost exclusively females |
| Key treatment | SSRIs, risperidone, behavioral/educational therapy | Anticonvulsants, supportive; trofinetide (2023) |
| Prognosis | Nonprogressive; many achieve professional careers with social handicap | Progressive deterioration; wheelchair-bound by teens; shortened lifespan |
| Famous cases | Elon Musk, Greta Thunberg, Anthony Hopkins, Temple Grandin | No public figures due to severity of disability |
Sources: Adams & Victor's Principles of Neurology 12e; Thompson & Thompson Genetics in Medicine 9e; Tietz Textbook of Laboratory Medicine 7e; Kaplan & Sadock's Comprehensive Textbook of Psychiatry